Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTK | P33981 | 2/20 | 0.43 |
| ▸ | SRC | P12931 | 7/20 | 0.42 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.41 |
| ▸ | PTK2 | Q05397 | 6/20 | 0.40 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 2/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
| ▸ | BTK | Q06187 | 1/20 | 0.39 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30962959 | 0.91 | LCK (0.42) | SRCALKKCNH2LCKJAK3 | |
| SCHEMBL30962731 | 0.90 | SRC (0.44) | TTKSRCMAP4K1PTK2ALK | |
| SCHEMBL30962820 | 0.89 | SRC (0.47) | TTKSRCLCKJAK3BTK | |
| SCHEMBL30962854 | 0.84 | LCK (0.42) | TTKSRCMAP4K1ALKKCNH2 | |
| SCHEMBL30962929 | 0.82 | SRC (0.46) | TTKSRCMAP4K1LCKJAK3 | |
| SCHEMBL30962930 | 0.82 | SRC (0.46) | TTKSRCMAP4K1LCKJAK3 | |
| SCHEMBL30962793 | 0.81 | LCK (0.43) | SRCMAP4K1LCK | |
| SCHEMBL30962591 | 0.81 | LCK (0.43) | SRCMAP4K1LCK | |
| SCHEMBL30962853 | 0.80 | TNK2 (0.48) | SRCPTK2LCKJAK3BTK | |
| SCHEMBL30962832 | 0.80 | PTK2 (0.43) | SRCMAP4K1PTK2LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642767-A1 | PYRIMIDINE CARBOXAMIDE COMPOUNDS | Acrivon Therapeutics, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |